Publications

Found 1 results
Filters: Author is N. Pattarachotanant  [Clear All Filters]
2010
N. Pattarachotanant, Sritharathikhun, T., Suttirat, S., and Tencomnao, T., Association of C/T polymorphism in intron 14 of the dopamine transporter gene (rs40184) with major depression in a northeastern Thai population, vol. 9, pp. 565-572, 2010.
Bonhomme N and Esposito E (1998). Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review. J. Clin. Psychopharmacol. 18: 447-454. http://dx.doi.org/10.1097/00004714-199812000-00005 PMid:9864076   Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, et al. (1995). The dopamine transporter: immunochemical characterization and localization in brain. J. Neurosci. 15: 1714-1723. PMid:7534339   Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, et al. (1995). Association of attention-deficit disorder and the dopamine transporter gene. Am. J. Hum. Genet. 56: 993-998. PMid:7717410 PMCid:1801209   Davidson RJ, Pizzagalli D and Nitschke JB (2002). The Representation and Regulation of Emotion in Depression. Perspectives from Affective Neuroscience. In: Handbook of Depression (Gotlib IH and Hammen CL, eds.). Guilford, New York, 219-244. PMid:12109826   Dunlop BW and Nemeroff CB (2007). The role of dopamine in the pathophysiology of depression. Arch. Gen. Psychiatry 64: 327-337. http://dx.doi.org/10.1001/archpsyc.64.3.327 PMid:17339521   Frisch A, Postilnick D, Rockah R, Michaelovsky E, et al. (1999). Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways. Mol. Psychiatry 4: 389-392. http://dx.doi.org/10.1038/sj.mp.4000536 PMid:10483058   Giros B, el Mestikawy S, Godinot N, Zheng K, et al. (1992). Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42: 383-390. PMid:1406597   Haeffel GJ, Getchell M, Koposov RA, Yrigollen CM, et al. (2008). Association between polymorphisms in the dopamine transporter gene and depression: evidence for a gene-environment interaction in a sample of juvenile detainees. Psychol. Sci. 19: 62-69. http://dx.doi.org/10.1111/j.1467-9280.2008.02047.x PMid:18181793   Haliassos A, Chomel JC, Grandjouan S, Kruh J, et al. (1989a). Detection of minority point mutations by modified PCR technique: a new approach for a sensitive diagnosis of tumor-progression markers. Nucleic Acids Res. 17: 8093-8099. http://dx.doi.org/10.1093/nar/17.20.8093 PMid:2573037 PMCid:334949   Haliassos A, Chomel JC, Tesson L, Baudis M, et al. (1989b). Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res. 17: 3606. http://dx.doi.org/10.1093/nar/17.9.3606 PMid:2726503 PMCid:317818   Mathers CD and Loncar D (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS. Med. 3: e442. http://dx.doi.org/10.1371/journal.pmed.0030442 PMid:17132052 PMCid:1664601   Mick E, Kim JW, Biederman J, Wozniak J, et al. (2008). Family based association study of pediatric bipolar disorder and the dopamine transporter gene (SLC6A3). Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B: 1182-1185. http://dx.doi.org/10.1002/ajmg.b.30745 PMid:18361424   Murray CJ and Lopez AD (1997). Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349: 1436-1442. http://dx.doi.org/10.1016/S0140-6736(96)07495-8   Nierenberg AA, Dougherty D and Rosenbaum JF (1998). Dopaminergic agents and stimulants as antidepressant augmentation strategies. J. Clin. Psychiatry 59 (Suppl 5): 60-63. PMid:9635549   Randrup A, Munkvad I, Pog R, Gerlach J, et al. (1975). Mania, Depression, and Brain Dopamine. In: Current Developments in Psychopharmacology. Vol. 2 (Essman W and Valzelli L, eds.). Spectrum Publications, New York, 206-248.   Robinson DS (2007). The role of dopamine and norepinephrine in depression. Prim. Psychiatry 14: 21-23.   Sullivan PF, Neale MC and Kendler KS (2000). Genetic epidemiology of major depression: review and meta-analysis. Am. J. Psychiatry 157: 1552-1562. http://dx.doi.org/10.1176/appi.ajp.157.10.1552 PMid:11007705   Tencomnao T and Boonmalert R (2009). Misgenotyping of dopamine receptor D1 gene -48A/G polymorphism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B: 447-449. http://dx.doi.org/10.1002/ajmg.b.30814 PMid:18615540   Todt U, Netzer C, Toliat M, Heinze A, et al. (2009). New genetic evidence for involvement of the dopamine system in migraine with aura. Hum. Genet. 125: 265-279. http://dx.doi.org/10.1007/s00439-009-0623-z PMid:19152006   Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, et al. (1992). Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14: 1104-1106. http://dx.doi.org/10.1016/S0888-7543(05)80138-7   Xiao J, Xin X, Luan X, Wei D, et al. (2006). A modified simple RFLP-PCR method for single nucleotide polymorphism (SNP) typing. Genet. Mol. Biol. 29: 562-565. http://dx.doi.org/10.1590/S1415-47572006000300028   Zhang R, Zhu Z, Zhu H, Nguyen T, et al. (2005). SNP Cutter: a comprehensive tool for SNP PCR-RFLP assay design. Nucleic Acids Res. 33: W489-W492. http://dx.doi.org/10.1093/nar/gki358 PMid:15980518 PMCid:1160119   Zhou K, Chen W, Buitelaar J, Banaschewski T, et al. (2008). Genetic heterogeneity in ADHD: DAT1 gene only affects probands without CD. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B: 1481-1487. http://dx.doi.org/10.1002/ajmg.b.30644 PMid:18553640